株式会社極東書店トップ > 商品一覧 > Progress in Cell Cycle Research: Volume 3. Softcover reprint of the original 1st ed. 1997
商品詳細
Progress in Cell Cycle Research: Volume 3. Softcover reprint of the original 1st ed. 1997
・ISBN 978-1-4613-7451-0 paper EUR 149.99
¥40,091.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Meijer, Laurent / Guidet, Silvana / Philippe, Michel (eds.), |
|---|---|
| シリーズ | (Progress in Cell Cycle Research) |
| 出版社 | (Springer-Verlag New York Inc., US) |
| 出版年月 | 2012 |
| ページ数 | 321 pp. |
| 言語 | ENG |
| ニュース番号 | <A05-53161> |
解説
The "Progress in Cell Cycle Research" series has been conceived to serve as a collection of reviews on various aspects of a fast growing biology field, the cell division cycle. These reviews do not pretend to cover all aspects of cell cycle regulation and mechanisms but rather focus on a few topics of particular interest in the recent literature. This third volume starts with a broad overview of the diversity of ways by which viruses subdue their host cell cycle (chapter 1). Of particular interest in this area is the case of HN which has recently been extensively investigated (chapter 2). Although most of our understanding of cell cycle regulation derives from work performed in yeast and animal cells, plant models, reviewed in chapter 3 for one of the best studied example, Arabidopsis, are starting to contribute significantly to the cell cycle general picture. In mammals, the regulation of cell division of two types of tissues, the intestine (chapter 4) and the developing muscle (chapter 5) are investigated in an interesting physiological context. Cell division is accompanied by a number of morphological changes. One of them, organelle transport, is starting to be better understood (chapter 6). The next few chapter summarise our knowledge of some essential regulators of the cell cycle. A still intriguing enzyme, casein kinase 2, is reviewed in detail in chapter 7. Some of the most studied cell cycle regulators are certainly the CKI's, cyclin-dependent kinases inhibitors (chapter 8).